DEA Telehealth Flexibilities for Prescribing Controlled Substances: What Practitioners Need to Know
As telehealth continues to shape the future of health care, providers must stay informed about evolving regulations, particularly those governing the remote prescribing of controlled substances. This webinar will provide an overview of the current and upcoming DEA telehealth flexibilities for prescribing Schedule II-V controlled substances, including a specific policy for prescribing buprenorphine to treat
Read more
